Three Months Ended December 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
108,542
|
$
|
95,142
|
$
|
108,542
|
$
|
95,142
|
||||||||
Gross margin
|
49.6
|
%
|
47.8
|
%
|
49.7
|
%
|
47.9
|
%
|
||||||||
Income from operations
|
$
|
16,670
|
$
|
19,126
|
$
|
19,164
|
$
|
20,420
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
11,809
|
$
|
15,565
|
$
|
12,596
|
$
|
18,069
|
||||||||
Basic EPS
|
$
|
0.20
|
$
|
0.27
|
$
|
0.21
|
$
|
0.31
|
||||||||
Diluted EPS (2)
|
$
|
0.18
|
$
|
0.23
|
$
|
0.19
|
$
|
0.27
|
Year Ended December 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
388,832
|
$
|
259,751
|
$
|
388,832
|
$
|
259,751
|
||||||||
Gross margin
|
47.2
|
%
|
44.2
|
%
|
47.4
|
%
|
44.4
|
%
|
||||||||
Income from operations
|
$
|
59,035
|
$
|
38,702
|
$
|
66,765
|
$
|
43,819
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
39,263
|
$
|
37,757
|
$
|
54,848
|
$
|
42,267
|
||||||||
Basic EPS
|
$
|
0.66
|
$
|
0.65
|
$
|
0.93
|
$
|
0.73
|
||||||||
Diluted EPS (2)
|
$
|
0.59
|
$
|
0.58
|
$
|
0.83
|
$
|
0.65
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of
GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized
loss on trading securities.
|
(2) |
Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.
|
• |
Shipments. Total shipments in 2022 were $539 million, versus
$372 million in 2021. Total shipments in the fourth quarter of 2022 were $197 million, versus $117 million in the fourth quarter of 2021. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems
awaiting customer acceptance for potential revenue in future quarters.
|
• |
Received Purchase Order for SAPS Tool from Major European Global Semiconductor Manufacturer. ACM announced the receipt of a first tool order for its Ultra C SAPS-V cleaning tool from a major Europe-based global semiconductor manufacturer. The tool is expected to be shipped to the prospective customer’s
European facility in the fourth quarter of 2023.
|
• |
First MLO-capable Ultra C pr Tool Qualified and in Mass Production at Power Semiconductor
Manufacturer in China. ACM expanded its Ultra C pr product offering to include metal lift-off (MLO) capabilities for power semiconductor manufacturing and wafer level packaging (WLP) applications.
MLO can be used to save an etch process step, reducing cost, optimizing cycle times and sharply reducing chemical demand at high temperatures. The first MLO-capable Ultra C pr tool has been qualified and released to mass production at a
power semiconductor manufacturer in China.
|
• |
Introduced Track Tool to Support Lithography for Semiconductor IC Manufacturing. ACM introduced its Ultra LithTM Track tool, marking its entry into the track market. ACM’s participation in this new product category is a natural evolution of its expertise in cleaning, coating and
developing systems. The first Ultra LithTM Track Coater/Developer ArF tool was delivered to a domestic Chinese customer in the fourth quarter of 2022, an i-line model is planned for delivery in 2023, and ACM also has begun
development of a KrF model.
|
• |
Introduced PECVD Tool to Support Logic & Memory Manufacturing. ACM introduced its Ultra PmaxTM Plasma-Enhanced Chemical Vapor Deposition (PECVD) tool as another major new product category, marking its entry into chemical vapor deposition (CVD) market.
|
• |
Revenue was $388.8 million, up 49.7%, reflecting continued
share gains by our flagship cleaning products and strong growth from our new products, particularly ECP tools.
|
• |
Gross margin was 47.2%, up from 44.2%. Non-GAAP gross
margin, which excludes stock-based compensation, was 47.4%, up from 44.4%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model. The Company expects gross margin to vary from period to period
due to a variety of factors, such as sales volume, product mix and favorable currency impacts from a stronger dollar versus the Chinese RMB.
|
• |
Operating expenses were $124.6 million, an increase of
63.6%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $117.4 million, up 64.3%. Operating expenses as a percent of revenue increased to 32.0% from 29.3%. Non-GAAP operating expenses as a percent
of revenue increased to 30.2% from 27.5%.
|
• |
Operating income was $59.0 million, up from $38.7 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $66.8 million, up from $43.8 million.
|
• |
Unrealized loss on trading securities was $7.9 million. The
loss reflects the change in market value of the indirect investment by ACM Shanghai in the STAR Market IPO shares of Semiconductor Manufacturing International Corporation (“SMIC”). The
value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
• |
Realized gain from sale of trading securities was $1.1
million due to the sale of a portion of ACM Shanghai’s shares of SMIC, which generated net proceeds of $4.5 million.
|
• |
Income tax expense was $16.8 million, up from $0.1 million.
As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986 that became effective on January 1, 2022, the effective tax rate for 2022 has increased, primarily due to a new requirement to capitalize and amortize previously deductible research and experimental expenses.
|
• |
Net income attributable to ACM Research, Inc. was $39.3
million, compared to net income of $37.8 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $54.8 million, as compared to
non-GAAP net income of $42.3 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.59, compared to $0.58. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.83, compared to $0.65.
|
• |
Cash and cash equivalents were $248.0 million at December
31, 2022, versus $336.3 million at September 30, 2022. Cash and cash equivalents, plus restricted cash and time deposits were $420.9 million at December 31, 2022,
versus $473.2 million at September 30, 2022.
|
• |
Revenue was $108.5 million, up 14.1%, reflecting continued
share gains by our flagship cleaning products and contribution from our new products, particularly ECP tools.
|
• |
Gross margin was 49.6%, up from 47.8%. Non-GAAP gross
margin, which excludes stock-based compensation, was 49.7%, up from 47.9%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model. The Company expects gross margin to vary from period to period
due to a variety of factors, such as sales volume, product mix and favorable currency impacts from a stronger dollar versus the Chinese RMB.
|
• |
Operating expenses were $37.1 million, an increase of 41.1%.
Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $34.8 million, up 38.4%. Operating expenses as a percent of revenue increased to 34.2% from 27.7%. Non-GAAP operating expenses as a percent of
revenue increased to 32.0% from 26.4%.
|
• |
Operating income was $16.7 million, down from $19.1 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $19.2 million, down from $20.4 million.
|
• |
Unrealized loss on trading securities was $1.7 million. The
loss reflects the change in market value of the indirect investment by ACM Shanghai in the STAR Market IPO shares of SMIC. The value is marked-to-market quarterly and is excluded in the
non-GAAP financial metrics.
|
• |
Income tax expense was $2.7 million, compared to $3.2
million. As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986 that became effective on January 1, 2022, the effective tax rate for 2022 has increased, primarily due to a new requirement to capitalize and amortize previously deductible research and experimental expenses.
|
• |
Net income attributable to ACM Research, Inc. was $11.8
million, compared to net income of $15.6 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $12.6 million, as compared to
non-GAAP net income of $18.1 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.18, compared to $0.23. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.19, compared to $0.27.
|
In the United States:
|
The Blueshirt Group
|
Yujia Zhai
|
|
+1 (860) 214-0809
|
|
yujia@blueshirtgroup.com
|
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.com
|
December 31, 2022
|
December 31, 2021
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except for par value)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
247,951
|
$
|
562,548
|
||||
Restricted cash
|
500
|
519
|
||||||
Short-term time deposits
|
70,492
|
-
|
||||||
Trading securities
|
20,209
|
29,498
|
||||||
Accounts receivable
|
182,936
|
105,553
|
||||||
Income tax receivable
|
-
|
1,082
|
||||||
Other receivables
|
29,617
|
18,979
|
||||||
Inventories
|
393,172
|
218,116
|
||||||
Advances to related party
|
3,322
|
2,383
|
||||||
Prepaid expenses
|
15,607
|
14,256
|
||||||
Total current assets
|
963,806
|
952,934
|
||||||
Property, plant and equipment, net
|
82,875
|
14,042
|
||||||
Land use right, net
|
8,692
|
9,667
|
||||||
Operating lease right-of-use assets, net
|
2,489
|
4,182
|
||||||
Intangible assets, net
|
1,255
|
477
|
||||||
Long-term time deposits
|
101,956
|
-
|
||||||
Deferred tax assets
|
6,703
|
13,166
|
||||||
Long-term investments
|
17,459
|
12,694
|
||||||
Other long-term assets
|
50,265
|
45,017
|
||||||
Total assets
|
$
|
1,235,500
|
$
|
1,052,179
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
56,004
|
$
|
9,591
|
||||
Current portion of long-term borrowings
|
2,322
|
2,410
|
||||||
Related party accounts payable
|
14,468
|
7,899
|
||||||
Accounts payable
|
101,735
|
93,451
|
||||||
Advances from customers
|
153,773
|
52,824
|
||||||
Deferred revenue
|
4,174
|
3,180
|
||||||
Income taxes payable
|
3,469
|
254
|
||||||
FIN-48 payable
|
6,686
|
2,282
|
||||||
Other payables and accrued expenses
|
52,201
|
31,735
|
||||||
Current portion of operating lease liability
|
1,382
|
2,313
|
||||||
Total current liabilities
|
396,214
|
205,939
|
||||||
Long-term borrowings
|
18,687
|
22,957
|
||||||
Long-term operating lease liability
|
1,107
|
1,869
|
||||||
Deferred tax liability
|
-
|
1,302
|
||||||
Other long-term liabilities
|
7,321
|
8,447
|
||||||
Total liabilities
|
423,329
|
240,514
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders’ equity:
|
||||||||
Class A Common stock
|
5
|
5
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
604,089
|
595,045
|
||||||
Retained earnings
|
94,426
|
63,732
|
||||||
Statutory surplus reserve
|
16,881
|
8,312
|
||||||
Accumulated other comprehensive income (loss)
|
(40,546
|
)
|
9,109
|
|||||
Total ACM Research, Inc. stockholders’ equity
|
674,856
|
676,204
|
||||||
Non-controlling interests
|
137,315
|
135,461
|
||||||
Total equity
|
812,171
|
811,665
|
||||||
Total liabilities and equity
|
$
|
1,235,500
|
$
|
1,052,179
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
(Unaudited)
( In thousands, except share and per
share data)
|
(Unaudited)
( In thousands, except share and per
share data)
|
|||||||||||||||
Revenue
|
$
|
108,542
|
$
|
95,142
|
$
|
388,832
|
$
|
259,751
|
||||||||
Cost of revenue
|
54,737
|
49,696
|
205,217
|
144,895
|
||||||||||||
Gross profit
|
53,805
|
45,446
|
183,615
|
114,856
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
12,395
|
9,273
|
39,889
|
26,733
|
||||||||||||
Research and development
|
17,835
|
12,914
|
62,226
|
34,207
|
||||||||||||
General and administrative
|
6,905
|
4,133
|
22,465
|
15,214
|
||||||||||||
Total operating expenses
|
37,135
|
26,320
|
124,580
|
76,154
|
||||||||||||
Income from operations
|
16,670
|
19,126
|
59,035
|
38,702
|
||||||||||||
Interest income
|
2,775
|
392
|
8,740
|
505
|
||||||||||||
Interest expense
|
(669
|
)
|
(191
|
)
|
(1,655
|
)
|
(765
|
)
|
||||||||
Realized gain from sale of trading securities
|
(20
|
)
|
-
|
1,116
|
-
|
|||||||||||
Unrealized gain (loss) on trading securities
|
1,707
|
(1,210
|
)
|
(7,855
|
)
|
607
|
||||||||||
Other income (expense), net
|
(6,634
|
)
|
52
|
3,315
|
(631
|
)
|
||||||||||
Equity income in net income of affiliates
|
3,014
|
3,601
|
4,666
|
4,637
|
||||||||||||
Income before income taxes
|
16,843
|
21,770
|
67,362
|
43,055
|
||||||||||||
Income tax expense
|
(2,660
|
)
|
(3,155
|
)
|
(16,798
|
)
|
(134
|
)
|
||||||||
Net income
|
14,183
|
18,615
|
50,564
|
42,921
|
||||||||||||
Less: Net income attributable to non-controlling interests
|
2,374
|
3,050
|
11,301
|
5,164
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
11,809
|
$
|
15,565
|
$
|
39,263
|
$
|
37,757
|
||||||||
Comprehensive income:
|
||||||||||||||||
Net income
|
14,183
|
18,615
|
50,564
|
42,921
|
||||||||||||
Foreign currency translation adjustment
|
21,232
|
3,436
|
(59,102
|
)
|
4,695
|
|||||||||||
Comprehensive Income (loss)
|
35,415
|
22,051
|
(8,538
|
)
|
47,616
|
|||||||||||
Less: Comprehensive income (loss) attributable to non-controlling interests and redeemable non-controlling interests
|
6,232
|
3,136
|
1,854
|
5,607
|
||||||||||||
Comprehensive income (loss) attributable to ACM Research, Inc.
|
$
|
29,183
|
$
|
18,915
|
$
|
(10,392
|
)
|
$
|
42,009
|
|||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.20
|
$
|
0.27
|
$
|
0.66
|
$
|
0.65
|
||||||||
Diluted
|
$
|
0.18
|
$
|
0.23
|
$
|
0.59
|
$
|
0.58
|
||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
59,268,562
|
58,588,386
|
59,235,975
|
57,654,708
|
||||||||||||
Diluted
|
64,198,325
|
66,325,821
|
65,341,771
|
65,356,716
|
`
|
Three Months Ended December 31,
|
Year Ended December 31,
|
||||||||||||||
($ in thousand)
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
74,603
|
$
|
61,886
|
$
|
272,939
|
$
|
189,208
|
||||||||
ECP (front-end and packaging), furnace and other technologies
|
20,213
|
19,460
|
77,482
|
33,210
|
||||||||||||
Advanced packaging (excluding ECP), services & spares
|
13,726
|
13,796
|
38,411
|
37,333
|
||||||||||||
Total Revenue By Product Category
|
$
|
108,542
|
$
|
95,142
|
$
|
388,832
|
$
|
259,751
|
||||||||
Wet cleaning and other front-end processing tools
|
$
|
79,333
|
$
|
74,946
|
$
|
308,528
|
$
|
202,268
|
||||||||
Advanced packaging, other processing tools, services and spares
|
29,209
|
20,196
|
80,304
|
57,483
|
||||||||||||
Total Revenue Front-end and Back-End
|
$
|
108,542
|
$
|
95,142
|
$
|
388,832
|
$
|
259,751
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Mainland China
|
$
|
104,167
|
$
|
94,296
|
$
|
377,752
|
$
|
258,615
|
||||||||
Other Regions
|
4,375
|
846
|
11,080
|
1,136
|
||||||||||||
$
|
108,542
|
$
|
95,142
|
$
|
388,832
|
$
|
259,751
|
Three Months Ended December 31,
|
||||||||||||||||||||||||||||||||
2022
|
2021
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-
operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-
operating adjustments |
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
108,542
|
$
|
-
|
$
|
-
|
$
|
108,542
|
$
|
95,142
|
$
|
-
|
$
|
-
|
$
|
95,142
|
||||||||||||||||
Cost of revenue
|
(54,737
|
)
|
(137
|
)
|
-
|
(54,600
|
)
|
(49,696
|
)
|
(108
|
)
|
-
|
(49,588
|
)
|
||||||||||||||||||
Gross profit
|
53,805
|
(137
|
)
|
-
|
53,942
|
45,446
|
(108
|
)
|
-
|
45,554
|
||||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(12,395
|
)
|
(600
|
)
|
-
|
(11,795
|
)
|
(9,273
|
)
|
(402
|
)
|
-
|
(8,871
|
)
|
||||||||||||||||||
Research and development
|
(17,835
|
)
|
(832
|
)
|
-
|
(17,003
|
)
|
(12,914
|
)
|
(314
|
)
|
-
|
(12,600
|
)
|
||||||||||||||||||
General and administrative
|
(6,905
|
)
|
(925
|
)
|
-
|
(5,980
|
)
|
(4,133
|
)
|
(470
|
)
|
-
|
(3,663
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
16,670
|
$
|
(2,494
|
)
|
$
|
-
|
$
|
19,164
|
$
|
19,126
|
$
|
(1,294
|
)
|
$
|
-
|
$
|
20,420
|
||||||||||||||
Unrealized gain (loss) on trading securities
|
1,707
|
-
|
1,707
|
-
|
(1,210
|
)
|
-
|
(1,210
|
)
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
11,809
|
$
|
(2,494
|
)
|
$
|
1,707
|
$
|
12,596
|
$
|
15,565
|
$
|
(1,294
|
)
|
$
|
(1,210
|
)
|
$
|
18,069
|
|||||||||||||
Basic EPS
|
$
|
0.20
|
$
|
0.21
|
$
|
0.27
|
$
|
0.31
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.18
|
$
|
0.19
|
$
|
0.23
|
$
|
0.27
|
||||||||||||||||||||||||
Year Ended December 31,
|
||||||||||||||||||||||||||||||||
2022
|
2021
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-
operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-
operating adjustments
|
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
388,832
|
$
|
-
|
$
|
-
|
$
|
388,832
|
$
|
259,751
|
$
|
-
|
$
|
-
|
$
|
259,751
|
||||||||||||||||
Cost of revenue
|
(205,217
|
)
|
(520
|
)
|
-
|
(204,697
|
)
|
(144,895
|
)
|
(397
|
)
|
-
|
(144,498
|
)
|
||||||||||||||||||
Gross profit
|
183,615
|
(520
|
)
|
-
|
184,135
|
114,856
|
(397
|
)
|
-
|
115,253
|
||||||||||||||||||||||
Sales and marketing
|
(39,889
|
)
|
(1,877
|
)
|
-
|
(38,012
|
)
|
(26,733
|
)
|
(1,802
|
)
|
-
|
(24,931
|
)
|
||||||||||||||||||
Research and development
|
(62,226
|
)
|
(2,565
|
)
|
-
|
(59,661
|
)
|
(34,207
|
)
|
(1,115
|
)
|
-
|
(33,092
|
)
|
||||||||||||||||||
General and administrative
|
(22,465
|
)
|
(2,768
|
)
|
-
|
(19,697
|
)
|
(15,214
|
)
|
(1,803
|
)
|
-
|
(13,411
|
)
|
||||||||||||||||||
Income from operations
|
$
|
59,035
|
$
|
(7,730
|
)
|
$
|
-
|
$
|
66,765
|
$
|
38,702
|
$
|
(5,117
|
)
|
$
|
-
|
$
|
43,819
|
||||||||||||||
Unrealized gain (loss) on trading securities
|
(7,855
|
)
|
-
|
(7,855
|
)
|
-
|
607
|
-
|
607
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
39,263
|
$
|
(7,730
|
)
|
$
|
(7,855
|
)
|
$
|
54,848
|
$
|
37,757
|
$
|
(5,117
|
)
|
$
|
607
|
$
|
42,267
|
|||||||||||||
Basic EPS
|
$
|
0.66
|
$
|
0.93
|
$
|
0.65
|
$
|
0.73
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.59
|
$
|
0.83
|
$
|
0.58
|
$
|
0.65
|